How AI describes ProFound AI

The ProFound Breast Health Suite from iCAD (now part of DeepHealth) uses AI to power cancer detection, density assessment, and personalized short-term risk evaluation across 2D and 3D mammography, with multi-vendor compatibility and workflow advantages. It includes Detection, Density, and Risk modules that provide automated scoring, standardized density reporting, and risk probabilities to tailor screening, with claims of higher cancer detection rates, faster readings, earlier detection, and fewer recalls. The Risk component is CE-marked and Health Canada licensed (not FDA-cleared) and available in the US for investigational use, and the BAC Assessment analyzes breast arterial calcifications to inform cardiovascular health, with the ProFound Scorecard delivering integrated case summaries.